Chayachinda, Chenchit http://orcid.org/0000-0002-0153-2231
Thamkhantho, Manopchai
Rekhawasin, Thanapa
Klerdklinhom, Chanakarn
Funding for this research was provided by:
Mahidol University
Article History
Received: 7 July 2023
Accepted: 24 March 2024
First Online: 4 April 2024
Declarations
:
: This study adhered to the Declaration of Helsinki principles. Approval was granted by the Siriraj Institutional Review Board (Si-32/2019 on February 11, 2019)<i>,</i> and the study was registered with the Thai Clinical Trials Registry (TCTR20190308004 on March 8, 2019). Eligible women provided written informed consent before participation.
: Not applicable.
: Bayer, Thailand, and Pacific Health Care, Thailand, donated the study medications and supported some project expenses, including participants’ transportation (totaling 150,000 Baht). C.C. and M.T. received honoraria from these companies for speaking at academic events. However, the companies had no role in the data analysis or manuscript preparation. T.R. and C.K. report no competing interests.